ArticleDupilumab for Dyshidrotic Eczema With Secondary Improvement in Eosinophilic Interstitial Lung DiseaseAuthor:Nicole J. Levin, MDPublish date: November 16, 2023Dupilumab may provide secondary efficacy in patients with dyshidrotic eczema who also have an eosinophilic condition such as eosinophilic pneumonia...Read More